Status:
AVAILABLE
Expanded Access Program for RP in Adults
Lead Sponsor:
Ocugen
Conditions:
Retinitis Pigmentosa
Eligibility:
All Genders
18-99 years
Brief Summary
This intermediate-size patient population expanded access program is to provide access to investigational product OCU400 for up to 75 patients with Retinitis Pigmentosa (RP) outside of the ongoing cli...
Detailed Description
This expanded access protocol provides access to OCU400 for a subset of patients. Subjects will undergo specific ocular testing included in the study. Subjects will follow-up with physical examination...
Eligibility Criteria
Inclusion
- Males or females ≥18 years of age at the time of informed consent.
- Confirmed clinical and CLIA certified genetic diagnosis of RP (except subjects with AD-NR2E3 mutation)
- Presence of photoreceptors as determined by spectral-domain optical coherence tomography (SD-OCT).
Exclusion
- Subject lacks evidence of outer nuclear layer, i.e., containing the nuclei of the retinal photoreceptors as determined by SD- OCT.
- Considered unsuitable for any reason that may either place the subject at increased risk during participation or interfere with the interpretation of the study outcomes by the Investigator, or the Sponsor after reviewing the subject medical history and condition.
- Previous treatment with a gene-therapy or cell therapy product, excluding OCU400.
- Previous treatment with any investigational drug or device within one year, excluding OCU400.
- Any contraindications for subretinal injection.
- Cataract surgery within 3 months. YAG capsulotomy within 1 month. Any other intraocular surgery within 6 months
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06574997
Last Update
July 28 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Associated Retina Consultants
Phoenix, Arizona, United States, 85020
2
Advanced Research
Deerfield Beach, Florida, United States, 33064
3
Erie Retina Research
Erie, Pennsylvania, United States, 16507
4
Gundersen Health
La Crosse, Wisconsin, United States, 54601